Association between hypertension and metabolic disorders among elderly patients in North Jordan

Nuha Alwardat1, Laura Di Renzo2, Renata Costa de Miranda3

  • 1Division of Clinical Nutrition and Nutrigenomics, Department of Biomedicine and prevention, University of Rome "Tor Vergata", Rome, Italy; PhD School of Applied Medical-Surgical Sciences, Faculty of Medicine and Surgery, University of Rome "Tor Vergata", Rome, Italy.

Insights

Hypertension, dyslipidemia, and hyperglycemia are key risk factors for cardiovascular disease in elderly Jordanians. Lifestyle changes and regular monitoring of blood pressure, lipids, and glucose are recommended to prevent these conditions.

Area of Science:

  • Cardiology
  • Endocrinology
  • Geriatrics

Background:

  • Hypertension (HTN), dyslipidemia, and hyperglycemia are significant risk factors for cardiovascular disease (CVD) in the elderly Jordanian population.
  • These conditions contribute to high morbidity and mortality rates among older adults in Jordan.
  • Understanding the interplay of these factors is crucial for effective CVD prevention strategies.

Purpose of the Study:

  • To evaluate serum lipid and glucose profiles in hypertensive patients compared to normotensive controls.
  • To identify risk factors associated with hypertension in the elderly Jordanian population.
  • To inform future strategies for preventing dyslipidemia, hyperglycemia, and subsequent hypertension.

Main Methods:

  • A cross-sectional study involving 200 participants (111 hypertensive, 89 normotensive) in North Jordan.
  • Data collection included sociodemographic factors, anthropometric measurements, blood pressure, and biochemical profiles (total cholesterol, triglyceride, LDL, HDL, fasting blood sugar).
  • Study conducted between June and October 2017.

Main Results:

  • Hypertensive subjects exhibited higher serum levels of total cholesterol, triglycerides, LDL, and fasting blood sugar, with lower HDL levels compared to normotensives (p < 0.01).
  • No significant differences in age, waist circumference, waist-to-height ratio, or BMI were observed between groups.
  • Overweight/obesity, abdominal obesity (WHtR), hyperglycemia, hypertriglyceridemia, and low HDL were identified as risk factors for hypertension.

Conclusions:

  • Future strategies should focus on preventing dyslipidemia and hyperglycemia to mitigate hypertension risk.
  • Lifestyle modifications and medical management are essential for risk factor control.
  • Regular monitoring of blood pressure, lipid, and glucose profiles is recommended for hypertensive patients within primary healthcare settings to prevent non-communicable diseases.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
245
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
223
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
194
What is Metabolism?00:52

What is Metabolism?

Overview
132.4K
Associative Learning01:27

Associative Learning

Associative learning is a fundamental concept in behavioral psychology, wherein a connection is established between two stimuli or events, leading to a learned response. This process is critical in understanding how behaviors are acquired and modified. Conditioning, the mechanism through which associations are formed, can be divided into two main types: classical conditioning and operant conditioning, each elucidating different aspects of associative learning.
Classical conditioning, also known...
1.5K
Association Areas of the Cortex01:21

Association Areas of the Cortex

Association areas are regions of the cerebral cortex that do not have a specific sensory or motor function. Instead, they integrate and interpret information from various sources to enable higher cognitive processes such as memory, learning, and decision-making. Some key association areas include the following:
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
9.5K